GUBBIOTTI, MARILENA
GUBBIOTTI, MARILENA
DIPARTIMENTO DI MEDICINA (attivo dal 01/01/2014 al 31/10/2020)
ABDOMINAL VS LAPAROSCOPIC SACROCOLPOPEXY: A RANDOMIZED CONTROLLED TRIAL, FINAL RESULTS
2015 DI BIASE, Manuel; Mearini, Luigi; Nunzi, Elisabetta; Pietropaolo, Amelia; Salvini, Eleonora; Gubbiotti, Marilena; Costantini, Elisabetta
Bladder and bowel dysfunction, adaptive behaviour and psychiatric profiles in adults affected by autism spectrum disorders
2019 Gubbiotti, M.; Balboni, G.; Bini, V.; Elisei, S.; Bedetti, C.; Marchiafava, M.; Giannantoni, A.
BOTULINUM A TOXIN REDUCES THE EXPRESSION OF VANILLOID AND CANNABINOID RECEPTORS IN "IN VITRO" PRIMARY HUMAN SMOOTH MUSCLES CELL CULTURES: PRELIMINARY RESULTS
2017 Giannantoni, A; de Vermandois, Jar; Salvini, E; Manasse, Gc; Cagini, R; Mearini, E; Gubbiotti, M
Clinical and urodynamic efficacy of Xeomin in the treatment of neurogenic detrusor overactivity: preliminary results.
2011 Proietti, Silvia; Giovannozzi, Silvia; Lepri, Emanuele; L., Lepri; Gubbiotti, Marilena; Giannantoni, Antonella
CLINICAL OUTCOMES OF SECOND-LINE TREATMENTS CYCLING IN REFRACTORY WET OVERACTIVE BLADDER PATIENTS BEFORE SWITCHING TO A THIRD-LINE THERAPY: A REAL WORLD OBSERVATIONAL STUDY
2018 Turco, M; Gubbiotti, M; de Vermandois, Jar; Maglia, D; Mearini, E; Giannantoni, A
Correlation between high pd-l1 and emt/invasive genes expression and reduced recurrence-free survival in blood-circulating tumor cells from patients with non-muscle-invasive bladder cancer
2021 Morelli, M. B.; Amantini, C.; de Vermandois, J. A. R.; Gubbiotti, M.; Giannantoni, A.; Mearini, E.; Maggi, F.; Nabissi, M.; Marinelli, O.; Santoni, M.; Cimadamore, A.; Montironi, R.; Santoni, G.
Desmopressin in the treatment of nocturia in patients affected by neurogenic bladder
2013 Giannantoni, Antonella; Gubbiotti, Marilena; Bruno, Raffaela; ROSSI DE VERMANDOIS, JACOPO ADOLFO; Nikaj, H; Proietti, Silvia
Desmopressin in the treatment of nocturia in patients affected by Parkinson's disease
2013 Proietti, Silvia; Gubbiotti, Marilena; ROSSI DE VERMANDOIS, JACOPO ADOLFO; Giannantoni, Antonella
EFFECTS OF BOTULINUM TOXIN TYPE A ON THE CELL GROWTH OF NORMAL HUMAN PROSTATE EPITHELIAL CELLS
2016 Gubbiotti, Marilena; Salvini, Eleonora; Boni, Andrea; Turco, Morena; Paladini, Alessio; Giannantoni, Antonella
IncobotulinumtoxinA in the treatment of neurogenic detrusor overactivity.
2011 Proietti, Silvia; Giovannozzi, Silvia; Lepri, Emanuele; Gubbiotti, Marilena; Porena, Massimo; Carbone, A; Giannantoni, Antonella
INFILTRAZIONI INTRADETRUSORIALI DI ONABOTULINUMTOXINA IN PAZIENTI AFFETTI DA SINDROME DELLA VESCICA IPERATTIVA: BEST- PRACTICE MANAGEMENT
2015 ROSSI DE VERMANDOIS, JACOPO ADOLFO; Gubbiotti, Marilena; Bevacqua, M.; Illiano, Ester; Costantini, Elisabetta; Giannantoni, Antonella
Intradetrusorial botulinum toxin in patients with multiple sclerosis: A neurophysiological study
2015 Conte, A; Giannantoni, Antonella; Gubbiotti, Marilena; Pontecorvo, S; Millefiorini, E; Francia, A; Porena, Massimo; Berardelli, A.
La disfunzione sessuale nei pazienti con sclerosi multipla: prevalenza e impatto dei trattamenti sintomatici
2016 Turco, Morena; ROSSI DE VERMANDOIS, JACOPO ADOLFO; Gubbiotti, Marilena; Salvini, Eleonora; Sarchielli, Paola; DI FILIPPO, Massimiliano; Giannantoni, Antonella
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis
2014 Di Filippo, M.; Proietti, S.; Gaetani, L.; Gubbiotti, M.; Di Gregorio, M.; Eusebi, P.; Calabresi, P.; Sarchielli, P.; Giannantoni, A.
ONABOTULINUM TOXIN A INTRADETRUSORIAL INJECTION MODALITY: SHALL WE TAKE A REST?
2016 Boni, Andrea; Gubbiotti, Marilena; Salvini, Eleonora; De Vermandois, Jr; Proietti, Silvia; Giannantoni, Antonella
ONABOTULINUMTOXIN A INTRADETRUSOR INJECTIONS IN THE TREATMENT OF REFRACTORY DETRUSOR OVERACTIVITY DUE TO PARKINSON'S DISEASE AND MULTIPLE SYSTEM ATROPHY
2018 Gubbiotti, M; de Vermandois, Jar; Turco, M; Quadrini, F; Maglia, D; Cagini, R; Mearini, E; Giannantoni, A
OnabotulinumtoxinA intradetrusorial injections improve sexual function in female patients affected by multiple sclerosis: preliminary results
2015 Giannantoni, Antonella; Proietti, Silvia; Giusti, G; Gubbiotti, Marilena; Millefiorini, E; Costantini, Elisabetta; Berardelli, A; Conte, A.
OnabotulinumtoxinA intravesical treatment in patients affected by overactive bladder syndrome: best practice in real-life management
2015 Giannantoni, Antonella; Proietti, Silvia; Costantini, Elisabetta; Gubbiotti, Marilena; ROSSI DE VERMANDOIS, JACOPO ADOLFO; Porena, Massimo
OVERACTIVE BLADDER, URINARY INCONTINENCE AND DEPRESSION
2018 Giannantoni, A; Gubbiotti, M; Mearini, E; Balducci, Pm; de Vermandois, Jar
Pharmacologic goals in interstitial cystitis/bladder pain syndrome
2017 Giannantoni, Antonella; Gubbiotti, Marilena; Yoshimura, Naoki; Andersson, Karl-Erik
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| ABDOMINAL VS LAPAROSCOPIC SACROCOLPOPEXY: A RANDOMIZED CONTROLLED TRIAL, FINAL RESULTS | 2015 | DI BIASE, Manuel; Mearini, Luigi; Nunzi, Elisabetta; Pietropaolo, Amelia; Salvini, Eleonora; Gubbiotti, Marilena; Costantini, Elisabetta | |
| Bladder and bowel dysfunction, adaptive behaviour and psychiatric profiles in adults affected by autism spectrum disorders | 2019 | Gubbiotti, M.; Balboni, G.; Bini, V.; Elisei, S.; Bedetti, C.; Marchiafava, M.; Giannantoni, A. | |
| BOTULINUM A TOXIN REDUCES THE EXPRESSION OF VANILLOID AND CANNABINOID RECEPTORS IN "IN VITRO" PRIMARY HUMAN SMOOTH MUSCLES CELL CULTURES: PRELIMINARY RESULTS | 2017 | Giannantoni, A; de Vermandois, Jar; Salvini, E; Manasse, Gc; Cagini, R; Mearini, E; Gubbiotti, M | |
| Clinical and urodynamic efficacy of Xeomin in the treatment of neurogenic detrusor overactivity: preliminary results. | 2011 | Proietti, Silvia; Giovannozzi, Silvia; Lepri, Emanuele; L., Lepri; Gubbiotti, Marilena; Giannantoni, Antonella | |
| CLINICAL OUTCOMES OF SECOND-LINE TREATMENTS CYCLING IN REFRACTORY WET OVERACTIVE BLADDER PATIENTS BEFORE SWITCHING TO A THIRD-LINE THERAPY: A REAL WORLD OBSERVATIONAL STUDY | 2018 | Turco, M; Gubbiotti, M; de Vermandois, Jar; Maglia, D; Mearini, E; Giannantoni, A | |
| Correlation between high pd-l1 and emt/invasive genes expression and reduced recurrence-free survival in blood-circulating tumor cells from patients with non-muscle-invasive bladder cancer | 2021 | Morelli, M. B.; Amantini, C.; de Vermandois, J. A. R.; Gubbiotti, M.; Giannantoni, A.; Mearini, E.; Maggi, F.; Nabissi, M.; Marinelli, O.; Santoni, M.; Cimadamore, A.; Montironi, R.; Santoni, G. | |
| Desmopressin in the treatment of nocturia in patients affected by neurogenic bladder | 2013 | Giannantoni, Antonella; Gubbiotti, Marilena; Bruno, Raffaela; ROSSI DE VERMANDOIS, JACOPO ADOLFO; Nikaj, H; Proietti, Silvia | |
| Desmopressin in the treatment of nocturia in patients affected by Parkinson's disease | 2013 | Proietti, Silvia; Gubbiotti, Marilena; ROSSI DE VERMANDOIS, JACOPO ADOLFO; Giannantoni, Antonella | |
| EFFECTS OF BOTULINUM TOXIN TYPE A ON THE CELL GROWTH OF NORMAL HUMAN PROSTATE EPITHELIAL CELLS | 2016 | Gubbiotti, Marilena; Salvini, Eleonora; Boni, Andrea; Turco, Morena; Paladini, Alessio; Giannantoni, Antonella | |
| IncobotulinumtoxinA in the treatment of neurogenic detrusor overactivity. | 2011 | Proietti, Silvia; Giovannozzi, Silvia; Lepri, Emanuele; Gubbiotti, Marilena; Porena, Massimo; Carbone, A; Giannantoni, Antonella | |
| INFILTRAZIONI INTRADETRUSORIALI DI ONABOTULINUMTOXINA IN PAZIENTI AFFETTI DA SINDROME DELLA VESCICA IPERATTIVA: BEST- PRACTICE MANAGEMENT | 2015 | ROSSI DE VERMANDOIS, JACOPO ADOLFO; Gubbiotti, Marilena; Bevacqua, M.; Illiano, Ester; Costantini, Elisabetta; Giannantoni, Antonella | |
| Intradetrusorial botulinum toxin in patients with multiple sclerosis: A neurophysiological study | 2015 | Conte, A; Giannantoni, Antonella; Gubbiotti, Marilena; Pontecorvo, S; Millefiorini, E; Francia, A; Porena, Massimo; Berardelli, A. | |
| La disfunzione sessuale nei pazienti con sclerosi multipla: prevalenza e impatto dei trattamenti sintomatici | 2016 | Turco, Morena; ROSSI DE VERMANDOIS, JACOPO ADOLFO; Gubbiotti, Marilena; Salvini, Eleonora; Sarchielli, Paola; DI FILIPPO, Massimiliano; Giannantoni, Antonella | |
| Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis | 2014 | Di Filippo, M.; Proietti, S.; Gaetani, L.; Gubbiotti, M.; Di Gregorio, M.; Eusebi, P.; Calabresi, P.; Sarchielli, P.; Giannantoni, A. | |
| ONABOTULINUM TOXIN A INTRADETRUSORIAL INJECTION MODALITY: SHALL WE TAKE A REST? | 2016 | Boni, Andrea; Gubbiotti, Marilena; Salvini, Eleonora; De Vermandois, Jr; Proietti, Silvia; Giannantoni, Antonella | |
| ONABOTULINUMTOXIN A INTRADETRUSOR INJECTIONS IN THE TREATMENT OF REFRACTORY DETRUSOR OVERACTIVITY DUE TO PARKINSON'S DISEASE AND MULTIPLE SYSTEM ATROPHY | 2018 | Gubbiotti, M; de Vermandois, Jar; Turco, M; Quadrini, F; Maglia, D; Cagini, R; Mearini, E; Giannantoni, A | |
| OnabotulinumtoxinA intradetrusorial injections improve sexual function in female patients affected by multiple sclerosis: preliminary results | 2015 | Giannantoni, Antonella; Proietti, Silvia; Giusti, G; Gubbiotti, Marilena; Millefiorini, E; Costantini, Elisabetta; Berardelli, A; Conte, A. | |
| OnabotulinumtoxinA intravesical treatment in patients affected by overactive bladder syndrome: best practice in real-life management | 2015 | Giannantoni, Antonella; Proietti, Silvia; Costantini, Elisabetta; Gubbiotti, Marilena; ROSSI DE VERMANDOIS, JACOPO ADOLFO; Porena, Massimo | |
| OVERACTIVE BLADDER, URINARY INCONTINENCE AND DEPRESSION | 2018 | Giannantoni, A; Gubbiotti, M; Mearini, E; Balducci, Pm; de Vermandois, Jar | |
| Pharmacologic goals in interstitial cystitis/bladder pain syndrome | 2017 | Giannantoni, Antonella; Gubbiotti, Marilena; Yoshimura, Naoki; Andersson, Karl-Erik |